Skip to main content

Table 4 The Cox proportional hazards model of PSA-PFS

From: Risk factors of PSA progression and overall survival in patients with localized and locally advanced prostate cancer treated with primary androgen deprivation therapy

  

Hazard-ratio

p

95 % CI

D’Amico

Low

1

  

Intermediate

1.212

0.493

0.693-2.119

High

2.116

0.003

1.289-3.492

J-CAPRA

Low

1

  

Intermediate

2.623

<0.001

1.942-3.542

Our new grouping

Low

1

  

Intermediate

1.936

<0.001

1.350-2.778

High

3.408

<0.001

2.269-5.117

  1. PSA-PFS: PSA progression-free survival
  2. 95 % CI: 95 % confidence interval
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us